betah-endorphin: antidiuretic effects in rats
- PMID: 700922
- DOI: 10.1111/j.1399-3011.1978.tb02882.x
betah-endorphin: antidiuretic effects in rats
Abstract
Human beta-endorphin (betah-EP) inhibits urine flow in rats. This antidiuretic effect of the peptide occurs after intravenous and intraventricular injections. Intravenously, betah-EP is 24 times more potent than morphine. Intraventricularly, betah-EP is 24 times more potent than morphine. Intraventricularly, betah-EP is effective at doses (0.45 microgram) which have no antidiuretic activity when injected intravenously. This fact suggests that one site of the antidiuretic action of betah-endorphin may be in the central nervous system. Animals tolerant to morphine are also tolerant to the antidiuretic effects of betah-endorphin.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources